Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma

Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma

Osteosarcoma is the most common primary malignant bone tumor with a high metastatic potential. Nowadays, there is a lack of new markers to identify prognosis of osteosarcoma patients with response to medical treatment. Recent studies have shown that hematological markers can reflect to some extent t...

Full description

Bibliographic Details
Main Authors: Longqing Li, Yang Wang, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Taojun Gong, Qing Chang, Jingqi Lin, Chuang Liu, Yi Luo, Li Min, Yong Zhou, Chongqi Tu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Immunology
Subjects:
osteosarcoma
hematological
prognostic
inflammation
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.879560/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.879560/full

Similar Items